SCHEDULE 13G/A: Armistice Capital and Steven Boyd Disclose 7.03% Stake in Cosmos Health Inc.
Beneficial Ownership Report
Armistice Capital, LLC and Steven Boyd have filed an amended Schedule 13G, disclosing a shared beneficial ownership of 7.03% of Cosmos Health Inc.'s common stock.
Summary
- Armistice Capital, LLC and Steven Boyd, collectively referred to as the 'Reporting Persons,' have filed an Amendment No. 3 to Schedule 13G regarding their beneficial ownership in Cosmos Health Inc.
- The filing indicates that the Reporting Persons beneficially own an aggregate of 1,917,710 shares of Cosmos Health Inc. Common Stock, representing 7.03% of the class.
- Armistice Capital, LLC, a Delaware entity, serves as the investment manager for Armistice Capital Master Fund Ltd., which is the direct holder of these shares.
- Steven Boyd, a U.S. citizen, is the managing member of Armistice Capital, LLC, and is therefore deemed to beneficially own the securities held by the Master Fund.
- Both Armistice Capital, LLC and Steven Boyd exercise shared voting and shared dispositive power over all 1,917,710 shares.
- The shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently indicate positive or negative sentiment regarding the company's performance or outlook.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of significant beneficial ownership by an investment firm and its principal, common in the financial industry for transparency regarding large stakes in publicly traded companies.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional ownership stake in Cosmos Health Inc., which can influence market perception and trading activity.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which required the filing of this statement (beneficial ownership threshold crossed or changed). |
| 05/15/2025 | Date the Schedule 13G/A filing was signed and submitted to the SEC. |
Keywords
Cosmos Health Inc., Armistice Capital, Steven Boyd, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Investment Management, Institutional Investor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.